| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.68B | 11.36B | 8.70B | 6.89B | 6.05B | 5.15B |
| Gross Profit | 1.11B | 1.17B | 816.42M | 633.36M | 572.50M | 505.24M |
| EBITDA | 771.69M | 773.16M | 3.22B | 405.05M | 300.44M | 224.29M |
| Net Income | 309.95M | 269.19M | 2.75B | 77.90M | 33.52M | 52.38M |
Balance Sheet | ||||||
| Total Assets | 11.27B | 9.06B | 7.91B | 5.60B | 4.72B | 5.07B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 43.57M | 2.57M | 1.93M | 3.91M | 7.52M |
| Total Debt | 2.65B | 3.04B | 2.98B | 2.93B | 2.72B | 2.66B |
| Total Liabilities | 6.64B | 6.02B | 5.38B | 3.47B | 3.08B | 3.47B |
| Stockholders Equity | 4.63B | 3.04B | 2.53B | 2.14B | 1.63B | 1.60B |
Cash Flow | ||||||
| Free Cash Flow | 71.08M | -262.17M | 2.49B | -359.61M | 197.00M | -271.98M |
| Operating Cash Flow | 73.22M | -248.82M | 2.50B | -357.49M | 198.56M | -268.63M |
| Investing Cash Flow | 128.99M | -41.32M | 156.84M | -58.36M | -8.07M | -51.21M |
| Financing Cash Flow | 902.62M | 300.46M | -64.84M | 413.51M | -194.09M | 312.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ₹7.28B | 11.65 | ― | 2.91% | -15.70% | -4.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ₹5.70B | 185.31 | ― | ― | 24.66% | 59.09% | |
58 Neutral | ₹6.41B | 43.53 | ― | ― | 23.11% | 1930.97% | |
54 Neutral | ₹3.88B | 296.89 | ― | 0.43% | 11.46% | -0.46% | |
51 Neutral | ₹3.82B | 14.95 | ― | ― | 29.26% | 46.09% | |
48 Neutral | ₹5.60B | -241.19 | ― | 6.20% | 86.75% | ― |
Sarveshwar Foods Limited has announced that Infomerics Valuation and Rating Private Limited has reaffirmed its credit ratings on the company’s bank facilities, maintaining a long-term rating of IVR BBB+ with a stable outlook and a short-term rating of IVR A2. The rated bank facilities have been marginally reduced to Rs 129.73 crore in total, indicating continued lender confidence in the company’s credit profile while reflecting a modest decrease in its sanctioned borrowing limits, which may signal prudent financial management and stable operational performance.
The reaffirmation of both long-term and short-term ratings suggests that Sarveshwar Foods remains in an investment-grade risk category, supporting its ability to access bank financing on relatively steady terms. For investors and other stakeholders, the unchanged rating with a stable outlook points to sustained creditworthiness in the near to medium term, even as the company operates with slightly lower overall bank facility limits.
Sarveshwar Foods Limited has announced that 10.2 crore warrants, issued on a preferential basis in July 2024 and entitling holders to subscribe to an equivalent number of equity shares within 18 months, have lapsed after the allottees failed to exercise their conversion option by the 24 January 2026 deadline. As a result, the company has forfeited the upfront payment of approximately Rs 23.78 crore—representing 25% of the issue price—received from these warrant holders, including several institutional investors, which halts the expected equity dilution while providing a non-refundable capital inflow that modestly strengthens the company’s balance sheet and alters the anticipated shareholder base composition.
Sarveshwar Foods Limited has approved the allotment of 37,50,000 equity shares of face value Re 1 each at an issue price of Rs 9.70 per share, following the conversion of an equivalent number of warrants issued on a preferential basis. The conversion, approved by the board through a resolution passed by circulation on 24 January 2026, brought in Rs 2.73 crore as 75% of the issue price payable on conversion, and increases the company’s paid-up equity share capital to Rs 123.27 crore, with the newly issued shares ranking pari passu with existing equity. This step forms part of a larger warrant issue previously approved in July 2024 and underscores the company’s continued use of preferential allotments to strengthen its equity base and fund its strategic and operational requirements, with implications for shareholding dilution and capital structure for current investors.